Cannabis and psychiatric disorders: it is not only addiction.
paper
Cited
Public
Unavailable
- Authors
- Leweke, F Markus; Koethe, Dagmar
- Year
- 2008
- Journal
- Addiction biology
- PMID
- 18482435
- DOI
- 10.1111/j.1369-1600.2008.00106.x
Since the discovery of the endocannabinoid system, a growing body of psychiatric research has emerged focusing on the role of this system in major psychiatric disorders like schizophrenia (SCZ), bipolar disorder (BD), major depression and anxiety disorder. Continuing in the line of earlier epidemiological studies, recent replication studies indicate that frequent cannabis use doubles the risk for psychotic symptoms and SCZ. Further points of clinical research interest are alterations of endocannabinoids and their relation to symptoms as well as postmortem analyses of cannabinoid CB(1) receptor densities in SCZ. A possible neurobiological mechanism for the deleterious influence of cannabis use in SCZ has been suggested, involving the disruption of endogenous cannabinoid signaling and functioning. Even though the number of studies is still limited for affective and anxiety disorders, previous results suggest these diseases to be exciting objectives of cannabinoid-associated research. Therefore, it became apparent that cannabis use is not only frequent in patients suffering from BD, but that it also induces manic symptoms in this group. In addition, prior antipsychotic treatment decreased the numerical density of CB(1) immunoreactive glial cells in bipolar patients. Although the data on the influence of cannabis use on the development of major depression is controversial, cannabinoid compounds could display a new class of medication, as suggested by the antidepressive effects of the fatty acid amino hydrolase inhibitor URB597 in animal models. With numerous open questions and controversial results, further research is required to specify and extend the findings in this area, which provides a promising target for novel pharmacotherapeutic interventions.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The prevalence and influencing factors of psychotic-like experiences in children and adolescents: a meta-analysis and systematic review. | Tang S et al. | β | 2026 | β |
| Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants. | Miranda A et al. | β | 2025 | β |
| International perspectives on physician knowledge, attitudes, and practices related to medical cannabis. | Syed SA et al. | β | 2025 | β |
| Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review. | CammΓ G et al. | β | 2025 | β |
| Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use. | Fang F et al. | β | 2024 | β |
| Tuning the properties of peptide imprinted nanoparticles for protein immunoprecipitation using magnetic streptavidin beads. | Elejaga-Jimeno A et al. | β | 2024 | β |
| Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling. | Stachowicz K | β | 2023 | β |
| International perspective on physician knowledge, attitude and practices related to medical cannabis | Syed SA et al. | β | 2023 | β |
| Neurosteroid influence on affective tone. | Walton NL et al. | β | 2023 | β |
| Cannabidiol for at risk for psychosis youth: A randomized controlled trial. | Amminger GP et al. | β | 2022 | β |
| Effects of regular cannabis and nicotine use on acute stress responses: chronic nicotine, but not cannabis use, is associated with blunted adrenocortical and cardiovascular responses to stress. | al'Absi M et al. | β | 2022 | β |
| Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review. | Prieto-Arenas L et al. | β | 2022 | β |
| Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. | Morris G et al. | β | 2022 | β |
| Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence. | Bright U et al. | β | 2022 | β |
| Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes. | Selloni A et al. | β | 2022 | β |
| Prevalence of anxiety and depression among engineering students consuming cannabis. | Vaziri-Harami R et al. | β | 2022 | β |
| The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. | Brunt TM et al. | β | 2022 | β |
| Translational models of cannabinoid vapor exposure in laboratory animals. | Moore CF et al. | β | 2022 | β |
| Cannabis use and resting state functional connectivity in adolescent bipolar disorder. | Sultan AA et al. | β | 2021 | β |
| CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial. | Baumgartner C et al. | β | 2021 | β |
| Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. | Onaemo VN et al. | β | 2021 | β |
| Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping. | al'Absi M et al. | β | 2021 | β |
| Prospects for the Use of Cannabinoids in Psychiatric Disorders. | Graczyk M et al. | β | 2021 | β |
| Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis. | GΓ³mez-Caballero A et al. | β | 2021 | β |
| The Green Sheep: Exploring the Perceived Risks and Benefits of Cannabis Among Young Military Members and Veterans. | Clary KL et al. | β | 2021 | β |
| The role of aberrant salience in the association between cannabis use frequency and psychotic experiences among racial and ethnic minoritized youth. | Anglin DM et al. | β | 2021 | β |
| Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. | Chadwick VL et al. | β | 2020 | β |
| Different pharmaceutical preparations of Ξ<sup>9</sup> -tetrahydrocannabinol differentially affect its behavioral effects in rats. | Rohleder C et al. | β | 2020 | β |
| Early-Life Adversity, Systemic Inflammation and Comorbid Physical and Psychiatric Illnesses of Adult Life. | Nettis MA et al. | β | 2020 | β |
| Effects of β<sup>9</sup>-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. | Raymundi AM et al. | β | 2020 | β |
| Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only. | De Aquino JP et al. | β | 2019 | β |
| Bipolar disorder and the endocannabinoid system. | Arjmand S et al. | β | 2019 | β |
| How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. | Hoch E et al. | β | 2019 | β |
| Is there a role for cannabidiol in psychiatry? | Khoury JM et al. | β | 2019 | β |
| Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions. | ZΓ‘dor F et al. | β | 2019 | β |
| The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review. | Batalla A et al. | β | 2019 | β |
| Cannabis consumption and psychosis or schizophrenia development. | Ortiz-Medina MB et al. | β | 2018 | β |
| Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function. | Sbarski B et al. | β | 2018 | β |
| High times for cannabis: Epigenetic imprint and its legacy on brain and behavior. | Szutorisz H et al. | β | 2018 | β |
| Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology. | Hudson R et al. | β | 2018 | β |
| The association between adolescent cannabis use and anxiety: A parallel process analysis. | Duperrouzel J et al. | β | 2018 | β |
| Alcohol use disorders are associated with increased affective lability in bipolar disorder. | Lagerberg TV et al. | β | 2017 | β |
| A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia. | D'Addario C et al. | β | 2017 | β |
| A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders. | Singh S et al. | β | 2017 | β |
| Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents. | Lippard ET et al. | β | 2017 | β |
| Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system? | Richards JR | β | 2017 | β |
| Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators. | Bourque J et al. | β | 2017 | β |
| Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior. | Dow-Edwards D et al. | β | 2017 | β |
| Lipids in psychiatric disorders and preventive medicine. | Schneider M et al. | β | 2017 | β |
| Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation. | Thomazeau A et al. | β | 2017 | β |
| Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. | Busquets-Garcia A et al. | β | 2017 | β |
| An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. | Wilsey B et al. | β | 2016 | β |
| Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | β | 2016 | β |
| Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. | RodrΓguez-MuΓ±oz M et al. | β | 2016 | β |
| Epigenetic Effects of Cannabis Exposure. | Szutorisz H et al. | β | 2016 | β |
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | Sherva R et al. | β | 2016 | β |
| PTSD: from neurobiology to pharmacological treatments. | Kelmendi B et al. | β | 2016 | β |
| Therapeutic Potential of Cannabinoids in Psychosis. | Leweke FM et al. | β | 2016 | β |
| Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein. | van der Doef TF et al. | β | 2015 | β |
| A systematic review of the antipsychotic properties of cannabidiol in humans. | Iseger TA et al. | β | 2015 | β |
| Cannabis: the never-ending, nefarious nepenthe of the 21st century: what should the clinician know? | Greydanus DE et al. | β | 2015 | β |
| Cannabis use and mania symptoms: a systematic review and meta-analysis. | Gibbs M et al. | β | 2015 | β |
| Cortical thinness and volume differences associated with marijuana abuse in emerging adults. | Mashhoon Y et al. | β | 2015 | β |
| Emerging targets in treating pain. | Chang DS et al. | β | 2015 | β |
| Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. | van Enkhuizen J et al. | β | 2015 | β |
| Mismatch negativity in tobacco-naΓ―ve cannabis users and its alteration with acute nicotine administration. | Impey D et al. | β | 2015 | β |
| Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors. | Shakoor S et al. | β | 2015 | β |
| Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder. | Neumeister A et al. | β | 2015 | β |
| Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. | Cabral GA et al. | β | 2015 | β |
| A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies. | Kedzior KK et al. | β | 2014 | β |
| At high risk and want to quit: marijuana use among adults with depression or serious psychological distress. | Shi Y | β | 2014 | β |
| Cannabis use and first manic episode. | Bally N et al. | β | 2014 | β |
| Immune system: a possible nexus between cannabinoids and psychosis. | SuΓ‘rez-Pinilla P et al. | β | 2014 | β |
| Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. | Girshkin L et al. | β | 2014 | β |
| Neurofunctional changes in adolescent cannabis users with and without bipolar disorder. | Bitter SM et al. | β | 2014 | β |
| Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. | Szutorisz H et al. | β | 2014 | β |
| Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or β9-tetrahydrocannabinol (THC). | Bossong MG et al. | β | 2014 | β |
| Smoking, alcohol consumption, and drug use among adolescents with psychiatric disorders compared with a population based sample. | Mangerud WL et al. | β | 2014 | β |
| Cannabis use and cannabis use disorders among individuals with mental illness. | Lev-Ran S et al. | β | 2013 | β |
| Default mode network in the effects of Ξ9-Tetrahydrocannabinol (THC) on human executive function. | Bossong MG et al. | β | 2013 | β |
| Determination of substance overdose in two Iranian centers: comparison between opioids and non-opioids. | Taghaddosinejad F et al. | β | 2013 | β |
| Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. | Neumeister A et al. | β | 2013 | β |
| Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. | Ceccarini J et al. | β | 2013 | β |
| Marijuana: current concepts(β ). | Greydanus DE et al. | β | 2013 | β |
| Medical use of cannabis. Cannabidiol: a new light for schizophrenia? | Deiana S | β | 2013 | β |
| Neurological soft signs in non-psychotic patients with cannabis dependence. | Dervaux A et al. | β | 2013 | β |
| No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample. | Pisanu C et al. | β | 2013 | β |
| Synaptic targets of Ξ9-tetrahydrocannabinol in the central nervous system. | Hoffman AF et al. | β | 2013 | β |
| The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. | Neumeister A | β | 2013 | β |
| Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase. | FiΕ‘ar Z | β | 2012 | β |
| Chemistry, metabolism, and toxicology of cannabis: clinical implications. | Sharma P et al. | β | 2012 | β |
| Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry. | Maremmani I et al. | β | 2012 | β |
| Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. | Trezza V et al. | β | 2012 | β |
| Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. | LΓ³pez-Gallardo M et al. | β | 2012 | β |
| Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. | Passie T et al. | β | 2012 | β |
| Neurophysiology of arthritis pain. | McDougall JJ et al. | β | 2012 | β |
| NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression. | Izumi Y et al. | β | 2012 | β |
| The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. | Viveros MP et al. | β | 2012 | β |
| Two-part random effects growth modeling to identify risks associated with alcohol and cannabis initiation, initial average use and changes in drug consumption in a sample of adult, male twins. | Gillespie NA et al. | β | 2012 | β |
| Cannabis involvement in individuals with bipolar disorder. | Agrawal A et al. | β | 2011 | β |
| Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. | Lueneberg K et al. | β | 2011 | β |
| Critical age windows for neurodevelopmental psychiatric disorders: evidence from animal models. | Marco EM et al. | β | 2011 | β |
| Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. | Marco EM et al. | β | 2011 | β |
| Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. | Minocci D et al. | β | 2011 | β |
| Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. | Schuelert N et al. | β | 2011 | β |
| [Managing the use of cannabis in a young population in primary care]. | Madoz-GΓΊrpide A et al. | β | 2011 | β |
| Marijuana-induced mania in a healthy adolescent: a case report. | Iskandar JW et al. | β | 2011 | β |
| Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons. | Adermark L | β | 2011 | β |
| Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. | Lafourcade M et al. | β | 2011 | β |
| The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. | Boucher AA et al. | β | 2011 | β |
| Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. | Malone DT et al. | β | 2010 | β |
| Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. | El-Alfy AT et al. | β | 2010 | β |
| Cannabinoid modulation of limbic forebrain noradrenergic circuitry. | Carvalho AF et al. | β | 2010 | β |
| [Cannabis and mood]. | Sanches RF et al. | β | 2010 | β |
| CB(1) cannabinoid receptors and their associated proteins. | Howlett AC et al. | β | 2010 | β |
| Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus. | SuΓ‘rez J et al. | β | 2010 | β |
| Impact of substance use on the physical health of patients with bipolar disorder. | Garcia-Portilla MP et al. | β | 2010 | β |
| In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. | Giuffrida A et al. | β | 2010 | β |
| Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD). | Hallak JE et al. | β | 2010 | β |
| Psychosis reactivity to cannabis use in daily life: an experience sampling study. | Henquet C et al. | β | 2010 | β |
| Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. | Sciolino NR et al. | β | 2010 | β |
| The neurobiology of schizophrenia: new leads and avenues for treatment. | Bray NJ et al. | β | 2010 | β |
| [Use of benzodiazepines and cannabis in young adults]. | KornΓΈr H et al. | β | 2010 | β |
| Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. | Koethe D et al. | β | 2009 | β |
| Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: compound-specific and area-specific distribution within the brain. | Barna I et al. | β | 2009 | β |
| Cannabis-induced bipolar disorder with psychotic features: a case report. | Khan MA et al. | β | 2009 | β |
| [Cannabis. Risk/benefit]. | Maldonado R | β | 2009 | β |
| Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). | Baeza I et al. | β | 2009 | β |
| Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. | SuΓ‘rez J et al. | β | 2009 | β |
| Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. | Haller J et al. | β | 2009 | β |
| Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies. | Janero DR et al. | β | 2009 | β |
| The endocannabinoid system as a target for modelling psychosis. | Koethe D et al. | β | 2009 | β |
| Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. | Schneider M | β | 2008 | β |